169 related articles for article (PubMed ID: 10444814)
1. [Glucocorticoid-induced diabetes mellitus in gastrointestinal diseases].
Kern W; Stange EF; Fehm HL; Klein HH
Z Gastroenterol; 1999 Jun; Suppl 1():36-42. PubMed ID: 10444814
[TBL] [Abstract][Full Text] [Related]
2. [Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy].
Meyer G; Badenhoop K
Med Klin (Munich); 2003 Apr; 98(5):266-70. PubMed ID: 12721671
[TBL] [Abstract][Full Text] [Related]
3. [Glucocorticoids and diabetes mellitus].
Vondra K; Hampl R
Vnitr Lek; 2006 May; 52(5):493-7. PubMed ID: 16771098
[TBL] [Abstract][Full Text] [Related]
4. Current smoking is an independent risk factor for new-onset diabetes mellitus during highdose glucocorticoid treatment.
Sugiyama T; Sugimoto T; Suzuki S; Sato Y; Tanaka T; Tatsuno I
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):616-20. PubMed ID: 25997545
[TBL] [Abstract][Full Text] [Related]
5. A study of steroid-induced diabetes mellitus in leprosy.
Papang R; John AS; Abraham S; Rao PS
Indian J Lepr; 2009; 81(3):125-9. PubMed ID: 20509340
[TBL] [Abstract][Full Text] [Related]
6. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL
J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232
[TBL] [Abstract][Full Text] [Related]
7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases.
Uzu T; Harada T; Sakaguchi M; Kanasaki M; Isshiki K; Araki S; Sugiomoto T; Koya D; Haneda M; Kashiwagi A; Yamauchi A
Nephron Clin Pract; 2007; 105(2):c54-7. PubMed ID: 17135768
[TBL] [Abstract][Full Text] [Related]
9. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids and cardiovascular risk factors.
Strohmayer EA; Krakoff LR
Endocrinol Metab Clin North Am; 2011 Jun; 40(2):409-17, ix. PubMed ID: 21565675
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
12. [Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids].
Barthel A; Scherbaum WA; Bornstein SR
Med Klin (Munich); 2003 Apr; 98(5):283-6. PubMed ID: 12721674
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.
Midtvedt K; Hjelmesaeth J; Hartmann A; Lund K; Paulsen D; Egeland T; Jenssen T
J Am Soc Nephrol; 2004 Dec; 15(12):3233-9. PubMed ID: 15579527
[TBL] [Abstract][Full Text] [Related]
14. A case series of steroid-induced diabetes mellitus in Zaria, Nigeria.
Babadoko AA; Ijei IP; Bello-Manga H; Hassan A; Manu M
Niger J Med; 2014; 23(3):267-70. PubMed ID: 25185386
[TBL] [Abstract][Full Text] [Related]
15. Steroid-induced iatrogenic disease after treating for pseudothrombocytopenia.
Sharma A; Pinto Pereira LM; Capildeo K; Charles K; Teelucksingh S
Clin Appl Thromb Hemost; 2011 Feb; 17(1):100-2. PubMed ID: 19903698
[TBL] [Abstract][Full Text] [Related]
16. [Disorder of glucose metabolism regulation in patients with multiple myeloma treated with high doses of corticosteroids at our clinic in 2004].
Pospísilová Y; Adam Z
Vnitr Lek; 2007 Jan; 53(1):18-23. PubMed ID: 17472011
[TBL] [Abstract][Full Text] [Related]
17. The potential biological mechanisms of arsenic-induced diabetes mellitus.
Tseng CH
Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
[TBL] [Abstract][Full Text] [Related]
18. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, classification, and pathogenesis of diabetes mellitus.
Lebovitz HE
J Clin Psychiatry; 2001; 62 Suppl 27():5-9; discussion 40-1. PubMed ID: 11806489
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
Rajamand N; Ungerstedt U; Brismar K
Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
